Design Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Design Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Design Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Design Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $78k | 10k | 7.53 |
| 2025-03-31 | $73k | 19k | 3.86 |
| 2024-12-31 | $119k | 19k | 6.17 |
| 2024-09-30 | $104k | 19k | 5.38 |
| 2024-06-30 | $0 | 0 | 0.00 |
| 2023-06-30 | $139k | 22k | 6.30 |
| 2023-03-31 | $127k | 22k | 5.77 |
| 2022-12-31 | $226k | 22k | 10.26 |
| 2022-09-30 | $369k | 22k | 16.72 |
| 2022-06-30 | $236k | 17k | 14.00 |
| 2022-03-31 | $273k | 17k | 16.15 |
| 2021-12-31 | $233k | 11k | 21.45 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors